Home Newsfeeds JP Morgan Reiterates Overweight on Uber Technologies, Maintains $52 Price Target

JP Morgan Reiterates Overweight on Uber Technologies, Maintains $52 Price Target

JP Morgan analyst Doug Anmuth reiterates Uber Technologies (NYSE:UBER) with a Overweight and maintains $52 price target.

byBenzinga Newsdesk

February 9, 2023

1 minute read

JP Morgan analyst Doug Anmuth reiterates Uber Technologies (NYSE:UBER) with a Overweight and maintains $52 price target.

Benchmark Reiterates Buy on Quanex Building Prods, Maintains $31 Price Target

By Benzinga Newsdesk

March 7, 9:35 AM

Benchmark analyst Reuben Garner reiterates Quanex Building Prods (NYSE:NX) with a Buy and maintains $31 price target.

Canopy Growth Launches Expanded Product Portfolio For The Quebec Market

By Vuk Zdinjak

June 8, 8:40 AM

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced partnership with VASCO Cannabis Inc. VASCO will produce and supply craft cannabis for distribution under the Vert Collab brand which, at launch, will include one new strain for the Quebec market.

CGC

Psilocybin For IBS Gets FDA Nod To Begin Clinical Trials At Mass. General Hospital

By Lara Goldstein

July 13, 3:48 PM

Tryp Therapeutics’ (OTCQB: TRYPF) latest Investigational New Drug (IND) application was approved by the FDA, enabling the company to begin Phase 2a clinical trials at the Massachusetts General Hospital (MGH) on the effects of psilocybin-assisted psychotherapy for adults with Irritable B

TRYPF